Menu Search
Equities

Mediclinic International PLC

MO4:FRA

Mediclinic International PLC

Actions
  • Price (EUR)5.65
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+31.76%
  • Beta--
Data delayed at least 15 minutes, as of Mar 30 2023 07:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mediclinic International PLC is a United Kingdom-based diversified international private healthcare services company. The Company is focused on providing specialist-orientated, multi-disciplinary services. Its segments include Switzerland, Southern Africa, and the United Arab Emirates. The Company comprises 74 hospitals, five subacute hospitals, two mental health facilities, 20 day case clinics and 20 outpatient clinics. Its Hirslanden operates 17 hospitals and four day case clinics in Switzerland with around 1900 inpatient beds; Mediclinic Southern Africa's operations included 50 hospitals (three of which in Namibia), five subacute hospitals, two mental health facilities and 14 day case clinics (four of which operated by Intercare) across South Africa, and around 8 650 inpatient beds; and Mediclinic Middle East operates seven hospitals, two day case clinics and 20 outpatient clinics with around 1 000 inpatient beds in the United Arab Emirates.

  • Revenue in GBP (TTM)3.38bn
  • Net income in GBP169.00m
  • Incorporated2012
  • Employees34.96k
  • Location
    Mediclinic International PLC6th Fl, 65 Gresham StreetLONDON EC2V 7NQUnited KingdomGBR
  • Phone+44 207 954 9600
  • Fax+44 207 954 9886
  • Websitehttps://www.mediclinic.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.